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Malignant  ﬁbrous  histiocytoma  (MFH)  is the  most  common  soft  tissue  sarcoma  of adults,  mostly  dis-
tributed  in the  thigh,  buttock  and  groin  (46%)  and  presents  rarely  in  the gastrointestinal  tract,  classiﬁedccepted  12 January 2011
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as  gastrointestinal  stromal  tumors  (GIST).  MFH  is  regarded  as  a  diagnosis  of exclusion,  essentially  syn-
onymous  with  an  undifferentiated  pleomorphic  sarcoma.  The  recent  report  presents  an 80-year-old  man
with  clinical  manifestations  of  rectal  bleeding  and  ﬁnal  diagnosis  of MFH  of rectum.  It  seems  that  radical
resection  and  adjuvant  radiation  is important  in the management  strategy  of  a  patient  with  such  a  rare
rectal  tumor.
© 2ectum
. Introduction
Sarcomas are malignant tumors that arise from mesenchymal
issue at any of the body sites.1 Malignant ﬁbrous histiocytoma
MFH) which was categorized in the 1970s is a malignant pleo-
orphic stromal tumor for which a deﬁnable line of differentiation
as not been found. The predisposing factors are genetics, expo-
ure to radiation or chemotherapy, chemical carcinogens, chronic
rritation and lymphedema. In nearly all instances, sarcomas are
hought to arise de novo and not from a preexisting benign lesion.2,3
he growth pattern of sarcomas is direct local extension, inﬁltrat-
ng adjacent tissues and structures, occasionally with skip areas.
pread to regional nodes is infrequent and vary according to the
umor grade and size.4 Distant metastases often develop later in
he course of the disease and are mostly compatible with the histo-
ogical grade, type and size of the tumor.5 The lungs are ultimately
nvolved in every patient who develops metastatic disease and this
epresents the predominant cause of death.6
The most common used staging system for soft tissue sarco-
as is American Joint Committee on Cancer (AJCC), which is not in
idespread use for non-extremity sarcomas.7 Histological grading
s another indicator of the degree of malignancy, the probability of
istant metastases and death from sarcoma but is a poor indica-
or of local recurrence. The preferred grading system in these cases
s a three level one, including grade I (well differentiated), grade II
moderately differentiated), and grade III (poorly differentiated).1,8
he size and depth of invasion are the most important prognostic
actors.9–11
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The most common distribution site of MFH  is extremities.12 The
recent case report is a rare presentation of MFH in rectum.
2.  Report of a case
An  80-year-old male was referred to the Department of Surgery,
Hazrat-e-Rasoul Hospital, with a 4-month history of rectal bleeding
associated with symptoms of fecal incontinency and a loss of weight
of about 10 kg. The patient also complained of intermittent bowel
obstruction symptoms.
On  physical examination the patient was an ill, malnourished
man presenting with low rest and squeezing pressure of anal canal.
A huge polypoid mass was  palpated on the anterior wall of rectum
in a distance of six cm to anal verge.
Laboratory tests revealed a moderate anemia (hemoglobin;
9/5 mg/ﬂ), an elevated estimated sedimentation rate (ESR) of
45 mm/h  and a serum carcinoembryogenic antigen (CEA) level of
1.9 ng/ml (normal values up to 2.5 ng/ml).
On radiologic investigation, the abdominopelvic CT scan yielded
the thickening of the anterior rectal wall without any invasion to
adjacent tissues and structures (see Figs. 1 and 2).
A  biopsy was obtained from the patient in another center which
reported a poorly differentiated adenocarcinoma.
The patient’s poor general condition, bowel obstruction and rec-
tal bleeding excluded the neoadjuvant chemoradiation therapy as
the ﬁrst line of treatment. The functional impairment of sphincter
complex conducted us to plan for an abdominoperineal resection,
perineal colostomy and appendicostomy under general anesthe-
Open access under CC BY-NC-ND license.sia. The size of the tumor was 5 × 4 × 2.5 cm, 2 cm away from the
dentate line.
The  histopathological report revealed a highly pleomorphic
neoplasm composed of large, pleomorphic giant cells as well
nse.
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pFig. 1. The horizontal cut of the patient’s pelvic CT scan.s spindle cells, arranged in fascicular and storiform pattern
ixed with inﬂammatory cells inﬁltration, including lymphocytes,
lasma cells, PMNs and multinucleated giant cells (Fig. 3). Immuno-
Fig. 2. The horizontal cut of the patient’s pelvic CT scan.
Fig. 3. H&E section shows a pleomorphic tumor with sarcomatous features.Fig. 4. CD117 (c-Kit) is negative in tumor cells.
histochemical (IHC) staining showed positive reaction of tumor
cells with 1 antitrypsin, CD68, Vimentin and focal SMA. Cytok-
eratin, EMA, CD117(c-Kit) and CD34 were all negative. These
ﬁndings, in combination with the histomorphology and IHC eval-
uations, were consistent with malignant ﬁbrous histiocytoma of
rectum.
3. Discussion
MFH  is extremely rare in the gastrointestinal tract, especially
rectum. Reviewing the available literatures, we found two cases
of MFH  of small intestine that were reported by Fu et al. in 1970.
The ﬁrst case was  a 70-year-old man  with recurrent right lower
quadrant pain and a tumor of cecum which was  diagnosed as MFH
and the second patient was  a 43-year-old man  who was admitted
with intussusception of the small intestine. An emergent laparo-
tomy revealed four pedunculated masses of small intestine which
were diagnoses as MFH  in the pathology report.13
Waxman et al. reported another case of MFH  in colon on 1983, in
which the neoplasm was considered as an incidental ﬁnding during
the diagnostic workup for diverticulitis of the sigmoid colon.14
We  found no more than one case of MFH  of rectum reported by
Dr. Singh et al. from India.15 The patient was a 55-year-old male
presented with tennesmus and signiﬁcant weight loss, who under-
went abdominoperineal resection and adjuvant chemoradiation
therapy.
Fig. 5. Cytokeratin does not stain tumoral cells.
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Fig. 6. Diffuse and intense positivity of tumor cells with A1-antitrypsin.
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sFig. 7. Positivity of some tumor cells with CD68.
The most probable differential diagnosis of the recent case was
astrointestinal Stromal Tumor (GIST) which was  ruled out by neg-
tive staining with c-Kit (Fig. 4). Negative results for CK (Fig. 5), EMA
nd Vimentin positivity also ruled out the poorly differentiated car-
inoma which is the most common malignant neoplasm in this
egion and sarcomatoid carcinoma. Furthermore diffuse and strong
taining with 1 antitripsin (Fig. 6) as well as positive reaction with
D68 (Fig. 7) conﬁrmed the diagnosis of MFH.
Surgical resection is the most potentially effective therapy for
oft tissue sarcomas regardless of their site of origin. AdjuvantPEN  ACCESS
ery Case Reports 2 (2011) 111– 113 113
radiation  therapy is recommended for patients with high grade sar-
comas beneﬁcial for local control. At present the role of adjuvant
chemotherapy for sarcomas remains unclear.3
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